Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05700669 | Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors | completed | Phase 1 / Phase 2 | 3 | Valerio TherapeuticsINDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06601205 | Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.(2F) | completed | Phase 2 / Phase 3 | 125 | Ente Ospedaliero Ospedali GallieraOTHER | 1 | Sep 19, 2024 |
| clinicaltrials |
| NCT06604247 | The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients | completed | N/A | 18 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06604377 | Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image Features | completed | — | 203 | Ruijin HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03579680 | De-implementation of Low Value Castration for Men With Prostate Cancer(DeADT) | completed | N/A | 60 | University of MichiganOTHER | 1 | Sep 5, 2024 | clinicaltrials |
| NCT03867357 | Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia | completed | — | 60 | Seattle Institute for Biomedical and Clinical ResearchOTHER | 1 | Sep 4, 2024 | clinicaltrials |
| NCT02566772 | Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer | completed | Phase 1 | 130 | Taiho Oncology, Inc.INDUSTRY | 4 | Sep 3, 2024 | clinicaltrials |
| NCT01272050 | Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery | completed | Phase 3 | 350 | Swiss Cancer InstituteOTHER | 3 | Aug 28, 2024 | clinicaltrials |
| NCT02431676 | Survivorship Promotion In Reducing IGF-1 Trial(SPIRIT) | completed | Phase 2 | 121 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT03473925 | Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034) | completed | Phase 2 | 107 | Merck Sharp & Dohme LLCINDUSTRY | 5 | Aug 28, 2024 | clinicaltrials |
| NCT03870269 | Using Virtual Reality (VR) Models for Robotic Prostatectomy - UNC | completed | N/A | 28 | Ceevra, Inc.INDUSTRY | 1 | Aug 28, 2024 | clinicaltrials |
| NCT00936936 | High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | completed | Phase 2 | 64 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT01716702 | A Feasibility Study of an Online Intervention for Sexual Rehabilitation in Prostate Cancer | completed | N/A | 18 | Nova Scotia Health AuthorityOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT04485767 | RESIST-ADT (Androgen Deprivation Therapy) | completed | N/A | 21 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT05615909 | PRO-MR-RT Systematic Patient-reported Outcomes to Pelvic Online MRgRT | completed | — | 156 | Odense University HospitalOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT04067960 | Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer | completed | Early Phase 1 | 197 | Mayo ClinicOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT00953277 | Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer | completed | Phase 4 | 12 | Axogen CorporationINDUSTRY | 1 | Aug 12, 2024 | clinicaltrials |
| NCT05132868 | Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling | completed | N/A | 78 | Stanford UniversityOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT03133286 | Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)(RADIANT) | completed | — | 16 | DxTerity DiagnosticsINDUSTRY | 1 | Aug 7, 2024 | clinicaltrials |
| NCT01685268 | A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate | completed | Phase 1 / Phase 2 | 49 | Astex Pharmaceuticals, Inc.INDUSTRY | 4 | Aug 2, 2024 | clinicaltrials |
| NCT03336983 | Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients(BonEnza) | completed | Phase 2 | 126 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Aug 1, 2024 | clinicaltrials |
| NCT03339635 | Short-term Testosterone Replacement in Testicular Cancer Survivors | completed | Phase 2 | 32 | University Medical Center GroningenOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT04488068 | Transpelvic Magnetic Stimulation to Improve Urogenital Function | completed | N/A | 12 | VA Office of Research and DevelopmentFED | 1 | Jul 29, 2024 | clinicaltrials |
| NCT05120973 | Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer.(SPLIT) | completed | — | 26 | The Netherlands Cancer InstituteOTHER | 1 | Jul 29, 2024 | clinicaltrials |
| NCT06145243 | Comparison of the Effectiveness of Supervised, Video-based and Home-based Resistance Exercise Program in Patients With Prostate Cancer | completed | N/A | 60 | Acibadem UniversityOTHER | 1 | Jul 19, 2024 | clinicaltrials |
| NCT03017417 | A COMbined progRamme of Exercise and Dietary ADvice in mEn With Castrate Resistant Prostate Cancer(COMRADE) | completed | N/A | 31 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Jul 18, 2024 | clinicaltrials |
| NCT03389451 | 68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer | completed | Phase 2 / Phase 3 | 30 | Michael Graham PhD, MDOTHER | 1 | Jul 12, 2024 | clinicaltrials |
| NCT04701021 | TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy | completed | Phase 1 | 12 | Ultimovacs ASAINDUSTRY | 1 | Jul 8, 2024 | clinicaltrials |
| NCT03030625 | VMAT for Dominant Intraprostatic Lesion(CaP-VMAT-DIL) | completed | N/A | 30 | Fundación de Investigación Biomédica - Hospital Universitario de La PrincesaOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06484127 | Heterogeneity of Tertiary Lymphoid Structures Predicts Distinct Malignancy and Immune Microenvironment in Prostate Cancer: a Retrospective Cohort Study | completed | — | 200 | Fudan UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT03220945 | Comprehensive Yoga Program (SKY) as Adjunct Therapy for Prostate Cancer | completed | N/A | 45 | Emory UniversityOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT04408924 | Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer(CYCLONE 1) | completed | Phase 2 | 44 | Eli Lilly and CompanyINDUSTRY | 3 | Jun 25, 2024 | clinicaltrials |
| NCT04284761 | A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer(Biolen-PC) | completed | Phase 1 | 17 | Alessa Therapeutics Inc.INDUSTRY | 3 | Jun 24, 2024 | clinicaltrials |
| NCT00341939 | Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data | completed | — | 484 | National Cancer Institute (NCI)NIH | 1 | Jun 13, 2024 | clinicaltrials |
| NCT03276572 | Phase I Trial of 225Ac-J591 in Patients With mCRPC | completed | Phase 1 | 32 | Weill Medical College of Cornell UniversityOTHER | 1 | Jun 13, 2024 | clinicaltrials |
| NCT03275857 | Cisplatin in Castration Resistant Prostate Cancer | completed | Early Phase 1 | 12 | University of RochesterOTHER | 1 | Jun 10, 2024 | clinicaltrials |
| NCT05324098 | Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy | completed | N/A | 47 | University of California, San FranciscoOTHER | 1 | Jun 10, 2024 | clinicaltrials |
| NCT04986280 | Diagnostic Accuracy and Performance of 18F-PSMA-1007 | completed | — | 174 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Jun 7, 2024 | clinicaltrials |
| NCT01194271 | Neoadjuvant Ipilimumab in Prostate Cancer | completed | Phase 2 | 19 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 6, 2024 | clinicaltrials |
| NCT05141760 | 18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients | completed | Phase 2 | 150 | University of AlbertaOTHER | 1 | Jun 6, 2024 | clinicaltrials |
| NCT03943368 | Using Virtual Reality (VR) Models for Robotic Prostatectomy | completed | N/A | 92 | Ceevra, Inc.INDUSTRY | 1 | Jun 4, 2024 | clinicaltrials |
| NCT00002981 | PET Scan in Treating Patients With Metastatic Prostate Cancer | completed | N/A | 173 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 3, 2024 | clinicaltrials |
| NCT02933255 | PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer | completed | Phase 1 / Phase 2 | 24 | National Cancer Institute (NCI)NIH | 1 | May 31, 2024 | clinicaltrials |
| NCT05679193 | Perioperative Propranolol During Prostatectomy to Decrease Cancer Recurrence(PeP-RALP) | completed | Phase 2 | 40 | Oslo University HospitalOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT06166758 | Feasibility Study: Educational Genetic Test Video | completed | N/A | 14 | Virginia Commonwealth UniversityOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT02184533 | Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 15 | Stanford UniversityOTHER | 1 | May 28, 2024 | clinicaltrials |
| NCT02113657 | T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer | completed | Early Phase 1 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT03629756 | A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies | completed | Phase 1 | 48 | Arcus Biosciences, Inc.INDUSTRY | 2 | May 24, 2024 | clinicaltrials |
| NCT02830165 | Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery | completed | N/A | 11 | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 23, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Sep 19, 2024source: clinicaltrials